Decentralised Clinical Trial Regulatory Feasibility Assessor

Regulatory operations leads at CROs or sponsors use this agent when evaluating whether a proposed decentralised or hybrid trial design is operationally and regulatory permissible across the target countries before protocol finalisation. They face a patchwork of national telemedicine laws, remote consent regulations, and wearable data requirements that vary widely even within the EU.